Intercept Pharmaceuticals, Inc.
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
Last updated:
Abstract:
The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.
Status:
Application
Type:
Utility
Filling date:
6 Dec 2021
Issue date:
5 May 2022